4/9
08:09 am
rxrx
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
Low
Report
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
4/9
06:18 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
4/9
06:18 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
3/4
06:30 am
rxrx
Rating for RXRX
Medium
Report
Rating for RXRX
3/4
06:30 am
rxrx
Rating for RXRX
Medium
Report
Rating for RXRX
2/28
05:43 am
rxrx
Rating for RXRX
Medium
Report
Rating for RXRX
2/28
05:43 am
rxrx
Rating for RXRX
Medium
Report
Rating for RXRX